A major limitation of our results is the small number of patients (n = 3) in our case series; the role of the combination of enteral cilostazol and IV albumin in the amelioration of cerebral ischemia needs to be explored in a larger case series and possibly in a randomized controlled trial. Here, ALB is linked to brain ischemia.